BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 804748)

  • 1. Formaldehyde-ozone-induced fluorescence in gastrin-producing tumours.
    Larsson LI; Sundler F; Grimelius L; Håkanson R; Buffa R; Solcia E
    Virchows Arch A Pathol Anat Histol; 1975; 365(3):179-84. PubMed ID: 804748
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Majority and minority cell populations in GEP and bronchial endocrine tumours.
    Sundler F; Alumets J; Håkanson R
    Scand J Gastroenterol Suppl; 1979; 53():9-13. PubMed ID: 225792
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Formaldehyde-ozone-induced fluorescence in isolated gastrin granules.
    Larsson LI; Håkanson R; Ingemansson S; Sundler F
    Histochemistry; 1975 Jul; 44(2):197-200. PubMed ID: 1095534
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Glucagon, gastrin, and carcinoid tumors of the duodenum, pancreas, and stomach: polypeptide "apudomas" of the foregut.
    Friesen SR; Hermreck AS; Mantz FA
    Am J Surg; 1974 Jan; 127(1):90-101. PubMed ID: 4808693
    [No Abstract]   [Full Text] [Related]  

  • 5. Peptide-secreting tumours with special reference to the pancreas.
    Sircus W
    Gut; 1969 Jul; 10(7):506-15. PubMed ID: 4308902
    [No Abstract]   [Full Text] [Related]  

  • 6. Primary endocrine-secreting pancreatic tumors.
    Macaron C
    Am Fam Physician; 1980 Apr; 21(4):94-8. PubMed ID: 6103668
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Parathyroid gastrin and parathormone-producing tumour in the Zollinger-Ellison syndrome of MEN 1 origin.
    Santini D; Pasquinelli G; D'Alessandro L; Mazzoleni G; Taffurelli M; Campione O; Marrano D; Martinelli GN
    Virchows Arch A Pathol Anat Histopathol; 1991; 419(5):433-7. PubMed ID: 1684256
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Zollinger-Ellison syndrome. Ultrastructural and histochemical observations in a child with endocrine tumorlets of gastric antrum.
    Bhagavan BS; Hofkin GA; Woel GM; Koss LG
    Arch Pathol; 1974 Oct; 98(4):217-22. PubMed ID: 4416924
    [No Abstract]   [Full Text] [Related]  

  • 9. Gastrinomas in the duodenums of patients with multiple endocrine neoplasia type 1 and the Zollinger-Ellison syndrome.
    Pipeleers-Marichal M; Somers G; Willems G; Foulis A; Imrie C; Bishop AE; Polak JM; Häcki WH; Stamm B; Heitz PU
    N Engl J Med; 1990 Mar; 322(11):723-7. PubMed ID: 1968616
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Syndromic versus non-syndromic sporadic gastrin-producing neuroendocrine tumors of the duodenum: comparison of pathological features and biological behavior.
    Rosentraeger MJ; Garbrecht N; Anlauf M; Raffel A; Knoefel WT; Wiedenmann B; Klöppel G
    Virchows Arch; 2016 Mar; 468(3):277-87. PubMed ID: 26649731
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Pathomorphologic studies of the endocrine cells in the gastrointestinal mucosa. Physiology, cytochemistry and ultrastructure (author's transl].
    Mitschke H
    Veroff Pathol; 1977; 104():1-203. PubMed ID: 190818
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of somatostatin analog on peptide release and tumor growth in the Zollinger-Ellison syndrome.
    Mozell E; Woltering EA; O'Dorisio TM; Fletcher WS; Sinclair AJ; Hill D
    Surg Gynecol Obstet; 1990 Jun; 170(6):476-84. PubMed ID: 2188384
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Suppression and stimulation mechanisms controlling glucagon secretion in a case of islet-cell tumor producing glucagon, insulin, and gastrin.
    Tiengo A; Fedele D; Marchiori E; Nosadini R; Muggeo M
    Diabetes; 1976 May; 25(5):408-12. PubMed ID: 5326
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Malignant Zollinger-Ellison syndrome with gastrin-containing skin metastases.
    Colin-Jones DG; Copping RM; Gibbs DD; Sharr MM
    Lancet; 1969 Mar; 1(7593):492-4. PubMed ID: 4179572
    [No Abstract]   [Full Text] [Related]  

  • 15. Sporadic versus hereditary gastrinomas of the duodenum and pancreas: distinct clinico-pathological and epidemiological features.
    Anlauf M; Garbrecht N; Henopp T; Schmitt A; Schlenger R; Raffel A; Krausch M; Gimm O; Eisenberger CF; Knoefel WT; Dralle H; Komminoth P; Heitz PU; Perren A; Klöppel G
    World J Gastroenterol; 2006 Sep; 12(34):5440-6. PubMed ID: 17006979
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [The pathogenesis of the Zollinger-Ellison syndrome].
    Nechaĭ AI; Kalashnikov SA; Ivanov GN
    Vopr Onkol; 1990; 36(2):176-81. PubMed ID: 2316200
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of somatostatin on gastrin, insulin and glucagon secretion in two patients with Zollinger-Ellison syndrome.
    Fallucca F; Delle Fave G; Giangrande L; Del Balzo P; De Magistris L; Carratù R
    J Endocrinol Invest; 1981; 4(4):451-3. PubMed ID: 6120969
    [No Abstract]   [Full Text] [Related]  

  • 18. Studies with bombesin in the Zollinger--Ellison syndrome.
    Basso N; Lezoche E; Materia A; Passaro E; Speranza V
    Br J Surg; 1981 Feb; 68(2):97-100. PubMed ID: 7459630
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prospective study of the standard meal provocative test in Zollinger-Ellison syndrome.
    Frucht H; Howard JM; Stark HA; McCarthy DM; Maton PN; Gardner JD; Jensen RT
    Am J Med; 1989 Nov; 87(5):528-36. PubMed ID: 2573280
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pathomorphologic, biochemical, and diagnostic aspects of gastrinomas (Zollinger-Ellison syndrome).
    Creutzfeldt W; Arnold R; Creutzfeldt C; Track NS
    Hum Pathol; 1975 Jan; 6(1):47-76. PubMed ID: 45919
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.